LST1
Leukocyte-specific transcript 1 protein
Also known as: B144, D6S49E, LST-1, LST1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00453
- Gene
- LST1
- Ensembl
- ENSG00000204482
- Chromosome
- 6
- Canonical length
- 97 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a membrane protein that can inhibit the proliferation of lymphocytes. Expression of this gene is enhanced by lipopolysaccharide, interferon-gamma, and bacteria. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
97 residues, UniProt reviewed canonical sequence.
>O00453|LST1
1 MLSRNDDICI YGGLGLGGLL LLAVVLLSAC LCWLHRRVKR LERSWAQGSS EQELHYASLQ
61 RLPVPSSEGP DLRGRDKRGT KEDPRADYAC IAENKPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LST1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 181 nTPM
Expression across tissuesHPA
Tissue
- spleen: 181 nTPM
- bone marrow: 94 nTPM
- lung: 49 nTPM
- spinal cord: 39 nTPM
- midbrain: 25 nTPM
- appendix: 21 nTPM
Single-cell type
- kupffer cells: 967 nCPM
- neutrophils: 550 nCPM
- monocytes: 476 nCPM
- cdc: 433 nCPM
- hofbauer cells: 210 nCPM
- macrophages: 204 nCPM
Immune cell
- non-classical monocyte: 1,768 nTPM
- intermediate monocyte: 1,285 nTPM
- neutrophil: 1,151 nTPM
- eosinophil: 687 nTPM
- total PBMC: 544 nTPM
- classical monocyte: 424 nTPM
Brain region
- medulla oblongata: 7 nTPM
- white matter: 6 nTPM
- pons: 5.2 nTPM
- hypothalamus: 5.1 nTPM
- spinal cord: 4.4 nTPM
- thalamus: 4.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- -0.37
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- cell morphogenesis
- dendrite development
- immune response
- negative regulation of lymphocyte proliferation
- regulation of cell shape
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Leukocyte-specific transcript 1, LST-1
- LST-1 protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LST1 as an antibody target. Whether an autoantibody or antibody against LST1 could matter depends on whether native LST1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LST1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LST1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...